000 01707 a2200469 4500
005 20250513211258.0
264 0 _c20000612
008 200006s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI8139
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBoytim, M L
245 0 0 _aA human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cMay 2000
300 _a1447-53 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmino Acid Sequence
650 0 4 _aCell Membrane
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aHistocompatibility Antigens Class II
_xchemistry
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xmetabolism
650 0 4 _aLymphocyte Activation
650 0 4 _aModels, Biological
650 0 4 _aMolecular Sequence Data
650 0 4 _aPeptide Fragments
_xchemistry
650 0 4 _aPhosphoinositide-3 Kinase Inhibitors
650 0 4 _aPhosphorylation
650 0 4 _aReceptors, Interleukin-2
_xmetabolism
650 0 4 _aRibosomal Protein S6 Kinases
_xantagonists & inhibitors
650 0 4 _aSignal Transduction
650 0 4 _aT-Lymphocytes
_xmetabolism
650 0 4 _aTyrosine
_xmetabolism
700 1 _aLilly, P
700 1 _aDrouvalakis, K
700 1 _aLyu, S C
700 1 _aJung, R
700 1 _aKrensky, A M
700 1 _aClayberger, C
773 0 _tThe Journal of clinical investigation
_gvol. 105
_gno. 10
_gp. 1447-53
856 4 0 _uhttps://doi.org/10.1172/JCI8139
_zAvailable from publisher's website
999 _c10763695
_d10763695